Boston Partners’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
478,670
-264,963
-36% -$757K ﹤0.01% 608
2025
Q4
$1.84M Sell
743,633
-15,108
-2% -$36K ﹤0.01% 573
2025
Q3
$1.69M Buy
+758,741
New +$1.74M ﹤0.01% 581
2021
Q3
Sell
-8,998,144
Closed -$31M 672
2021
Q2
$31M Buy
8,998,144
+308,690
+4% +$1M 0.04% 296
2021
Q1
$23.8M Buy
8,689,454
+508,239
+6% +$1.44M 0.03% 317
2020
Q4
$25M Sell
8,181,215
-267,454
-3% -$721K 0.04% 293
2020
Q3
$19.1M Sell
8,448,669
-297,578
-3% -$746K 0.03% 295
2020
Q2
$23.1M Sell
8,746,247
-2,233,546
-20% -$5.27M 0.04% 279
2020
Q1
$25.3M Sell
10,979,793
-191,206
-2% -$692K 0.05% 266
2019
Q4
$52.1M Sell
11,170,999
-951,369
-8% -$4.22M 0.07% 239
2019
Q3
$56M Sell
12,122,368
-569,893
-4% -$2.73M 0.08% 237
2019
Q2
$59.3M Sell
12,692,261
-2,767,957
-18% -$12.4M 0.08% 228
2019
Q1
$66.5M Sell
15,460,218
-15,409,357
-50% -$70.8M 0.09% 216
2018
Q4
$121M Sell
30,869,575
-1,121,147
-4% -$4.79M 0.17% 154
2018
Q3
$146M Buy
+31,990,722
New +$153M 0.17% 153
2018
Q1
Sell
-77,061
Closed -$498K 731
2017
Q4
$498K Sell
77,061
-102,244
-57% -$654K ﹤0.01% 728
2017
Q3
$1.18M Buy
+179,305
New +$1.11M ﹤0.01% 712
2017
Q1
Sell
-27,441
Closed -$135K 763
2016
Q4
$135K Sell
27,441
-41,946
-60% -$226K ﹤0.01% 744
2016
Q3
$423K Hold
69,387
﹤0.01% 719
2016
Q2
$410K Hold
69,387
﹤0.01% 711
2016
Q1
$359K Hold
69,387
﹤0.01% 698
2015
Q4
$309K Hold
69,387
﹤0.01% 718
2015
Q3
$340K Buy
69,387
+9,932
+17% +$53.9K ﹤0.01% 687
2015
Q2
$363K Hold
59,455
﹤0.01% 692
2015
Q1
$342K Hold
59,455
﹤0.01% 686
2014
Q4
$370K Hold
59,455
﹤0.01% 699
2014
Q3
$389K Hold
59,455
﹤0.01% 702
2014
Q2
$419K Hold
59,455
﹤0.01% 696
2014
Q1
$441K Hold
59,455
﹤0.01% 692
2013
Q4
$437K Buy
+59,455
New +$435K ﹤0.01% 685

Other funds holding ABEV

Boston Partners's ABEV Position: Q1 2026 in Review

Boston Partners reduced its Ambev (ABEV) stake by 36% in Q1 2026, selling an estimated $757K and leaving 478,670 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Boston Partners first reported a position in ABEV in Q4 2013 and has held it in 30 quarters since. The position peaked at $146M in Q3 2018. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Boston Partners held 478,670 shares of Ambev worth $1.4M as of Q1 2026.
  • Boston Partners sold 264,963 Ambev shares in Q1 2026, an estimated $757K.
  • Ambev made up ﹤0.01% of Boston Partners's portfolio in Q1 2026, its #608 holding.
  • Boston Partners first reported a position in Ambev in Q4 2013 and has held it in 30 quarters since.
  • Boston Partners's Ambev position peaked at $146M in Q3 2018.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.